Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.
Ontology highlight
ABSTRACT: In December 2019, a new variant of SARS-CoV emerged, the so-called acute severe respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes the new coronavirus disease (COVID-19) and has been plaguing the world owing to its unprecedented spread efficiency, which has resulted in a huge death toll. In this sense, the repositioning of approved drugs is the fastest way to an effective response to a pandemic outbreak of this scale. Considering these facts, in this review we provide a comprehensive and critical discussion on the chemical aspects surrounding the drugs currently being studied as candidates for COVID-19 therapy. We intend to provide the general chemical community with an overview on the synthetic/biosynthetic pathways related to such molecules, as well as their mechanisms of
SUBMITTER: Batalha PN
PROVIDER: S-EPMC7676325 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA